HY-2195
N/A
Report date: 2022/12/26 09:41:10
NME
Base Information
Drug NameHY-2195
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesHengyi Biomedical Technology (Shanghai) Co Ltd
China Registration ClassClass 1 Chemical Drug in China
Develop Information
Active CompaniesHengyi Biomedical Technology (Shanghai) Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A